Walter Kiesinger

Venturis Therapeutics, Inc. operates as a biopharmaceutical company, which engages in the developing protein drug candidates to address diseases such as diabetic wounds, severe coronary heart disease and peripheral artery disease. The company develops injectable and topical formulations of its active pharmacological ingredient to facilitate the growth of new blood vessels in the heart, tissues and organs. It focuses on developing protein drug candidates to be used in the treatment of cardiovascular disease. CardioVascular BioTherapeutics was founded by Daniel C. Montano, Thomas J. Stegmann and Grant Gordon in March 1998 and is headquartered in Dallas, TX.

Phage Pharmaceuticals, Inc. manufactures therapeutic protein which makes use of a proprietary production method that improves upon well-established approaches for the manufacture of proteins and results in the production of simple, properly folded therapeutic proteins at high yields. The company was founded in 1998 and is headquartered in San Diego, CA.

FirmInvest AG is an independent asset manager based in Zurich, Switzerland. With a focus on trust, integrity, and independence, FirmInvest implements fully personalized investment solutions based on clients' specific needs and requirements. The Swiss company's services include asset management, active advisory, and family office services. With a team of experienced partners, FirmInvest offers expertise in equity and high-yield fixed income investing, as well as biotech investments. FirmInvest AG also provides additional solutions such as asset and portfolio consolidations, financial consulting, and succession planning. Founded in 1995 by Fabio L. B. Pelli and Frédéric M. Chanson, the company develops custom-made investment strategies for Swiss and international clients.

Mila Europe GmbH operates a shared-economy platform for crowd-source local service agents to solve support requests. It gives Friends & Pros the opportunity to make money easily using their technical skills. The company was founded by Manuel Grenacher in 2013 and is headquartered in Berlin, Germany.

Unique AG is a Swiss company that specializes in providing solutions for the wealth management and private banking sector. The company is based in Zurich, Switzerland. The company's focus is on improving metrics and automating manual processes. and has subsidiaries in Germany. Unique was founded in 2021 by Andreas Hauri and Manuel Grenacher, with Manuel Grenacher serving as the CEO since 2021.